• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number VBJR050502A
Device Problem Material Distortion (2977)
Patient Problem Fistula (1862)
Event Date 11/24/2015
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Warnings in gore viabahn endoprosthesis ifu states: w.L.Gore & associates has insufficient clinical and experimental data regarding the use of the gore viabahn endoprosthesis within stents or stent grafts (other than the gore viabahn endoprosthesis with heparin bioactive surface or the gore viabahn endoprosthesis) that have been implanted for less than 30 days.Other devices implanted for less than 30 days may interfere with the deployment of the gore viabahn endoprosthesis resulting in deployment failure or other device malfunctions.
 
Event Description
On (b)(6) 2015, a patient with highly calcified vessels underwent an endovascular procedure to treat an occluded common femoral and superficial femoral artery.The target lesions were accessed from the popliteal artery.A supera stent was placed in the common femoral artery.Lifestents were deployed in the superficial femoral artery.On (b)(6) 2015, the patient presented with a very large fistula at the access site in the popliteal artery.To repair the fistula, access was gained from contralateral leg, up and over the bifurcation.A sheath was used to advance the gore viabahn endoprosthesis through the stents implanted the day before.The gore viabahn endoprosthesis was advanced about half way through the stents when the gore viabahn endoprosthesis got hung up.Under fluoroscopy, it appeared that the tip of the gore viabahn endoprosthesis was expanding.Since the device and deployment line could not be retracted, a decision was made to deploy the gore viabahn endoprosthesis at its current location.The gore viabahn endoprosthesis was deployed but appeared distorted with the deployment line tangled around the distal portion of the device.Imaging also showed the radiopaque markers were sideways, into the left side of the image.In order to open the gore viabahn endoprosthesis, the proximal end of gore viabahn endoprosthesis was cannulated.Using the back end of a stiff guidewire and an expanded 5mm balloon, the device was opened close to the distal tip.The distal tip of the device was then cannulated with a wire, balloon was advanced and inflated, achieving full expansion of the gore viabahn endoprosthesis.To complete the procedure, a 90cm 8fr sheath was advanced beyond the previously implanted stents.A gore viabahn endoprosthesis was advanced and deployed, covering the fistula.
 
Manufacturer Narrative
Was corrected to 'yes'.Device remains in patient.Deployment line and delivery catheter were returned for evaluation.Evaluation was included in initial manufacturer report.
 
Manufacturer Narrative
(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
genevieve begay
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5316327
MDR Text Key34055160
Report Number2017233-2015-00905
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/30/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/13/2017
Device Catalogue NumberVBJR050502A
Device Lot Number13054699
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/11/2015
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/16/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age94 YR
-
-